Grossman Combined Medicine and Policy

The Harvard community, and the Boston healthcare community, lost an energetic leader April 1 with the death of Dr. Jerome Grossman.

The Harvard community, and the Boston healthcare community, lost an energetic leader April 1 with the death of Dr. Jerome Grossman.

Grossman—remembered in a Boston Globe obituary last weekend—directed the healthcare-delivery policy program at the Harvard Kennedy School, taught at the Tufts University School of Medicine, and was CEO of New England Medical Center (now known as Tufts Medical Center). His books included the forthcoming The Innovator's Prescription, co-written with Clayton M. Christensen, Cizik professor of business administration at Harvard Business School, and Jason Hwang, M.B.A. ’06.

Grossman's colleagues said he was particularly adept at reconciling medical knowledge and policy concerns. And, Gordon Vineyard, M.D. ’63, told the Globe, Grossman "had more ideas and a clearer thought process than anyone I ever encountered." Of talking with Grossman, he said, "The ideas came out so fast. Sometimes you'd like to go to the water fountain and have a sip. This was a fire hose."

Related topics

You might also like

Harvard Students, Alumna Named Rhodes and Marshall Scholars

Nine Rhodes and five Marshall scholars will study in the U.K. in 2026.

Five Questions with Michèle Duguay

A Harvard scholar of music theory on how streaming services have changed the experience of music

Harvard Faculty Discuss Tenure Denials

New data show a shift in when, in the process, rejections occur

Most popular

Harvard Revamps Controversial Public Health School Center

The health and human rights center had drawn attention for its Palestine-related program.

Getting to Mars (for Real)

Humans have been dreaming of living on the Red Planet for decades. Harvard researchers are on the case.

Explore More From Current Issue

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.